Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells

BACKGROUND: The mechanism of action of oral cladribine, recently licensed for relapsing multiple sclerosis, is unknown. OBJECTIVE: To determine whether cladribine depletes memory B cells consistent with our recent hypothesis that effective, disease-modifying treatments act by physical/functional dep...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Neurol
Autori principali: Ceronie, Bryan, Jacobs, Benjamin M., Baker, David, Dubuisson, Nicolas, Mao, Zhifeng, Ammoscato, Francesca, Lock, Helen, Longhurst, Hilary J., Giovannoni, Gavin, Schmierer, Klaus
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Berlin Heidelberg 2018
Soggetti:
Original Communication
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5937883/
https://ncbi.nlm.nih.gov/pubmed/29550884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-018-8830-y
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi